| |
AcuNetx Files For Patent Protection on Breakthrough Polygraph Technology
Torrance, California, March 4, 2008
TORRANCE, CA., March 4, 2008 . AcuNetx, Inc. (OTCBB: ANTX), announced today that it has
retained the international law firm of Patton Boggs (www.pattonboggs.com),
to file for worldwide patent protection on a unique technology it has developed for polygraph
applications - AcuNetx"s Physiological Detection of Deception (PDD) System.
With significant pilot data from an earlier study done under contract from the Department of Defense
Polygraph Institute, now known as Defense Academy for Credibility Assessment (www.dodpi.army.mil),
and with the AcuNetx PDD System having been recently selected for another university research project,
the company will now pursue other avenues of research & development, as well as commercial ventures,
for its PDD System.
The technology represents an entirely new approach to detecting truthfulness and relies on eye responses
which are proving to be an objective measure of deception. AcuNetx believes that the techniques underlying
the PDD system are novel and will eventually prevail as admissible evidence in courts of law.
"I have a special interest in the PDD system", says Ron Waldorf, CEO and co-inventor with Barbara Mauch,
the company Sr. V.P. of Technology. "The experience we have gained as a result of our research into eye responses,
research that has led to the development of FDA approved computer-based systems for analyzing eye movements related
to medical applications (www.intellinetx.com ), evolving into products for identifying motorists driving "Under
the Influence" (www.acunetx.com/hawkeye) and impaired workers (www.visionetx.com), has permitted us to
develop a powerful new tool for the law enforcement community and homeland security agencies. The PDD could
revolutionize the way in which we detect deception. Frankly, I feel very positive that we can develop –
scientifically and commercially – a product that can have a profound effect on the criminal justice system."
About AcuNetx, Inc.
AcuNetx markets a diverse line of diagnostic, analytical and therapeutic tools for medical
(audiologist, neurologists, otolaryngologists and physical therapists as well as hospitals,
clinics, and extended care facilities) and law enforcement applications. AcuNetx is headquartered
in Torrance, CA.
FOR FURTHER INFORMATION CONTACT:
Name: J. Astor
G.M. Astor & Associates
Telephone: 818 788 4346
gastor@acunetx.com
Safe Harbor for Forward-Looking Statements
This news release contains forward-looking statements that are made pursuant
to the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995. While these statements are made to convey to the public the
company’s progress, business opportunities and growth prospects, readers are
cautioned that such forward-looking statements represent management’s
opinion. Whereas management believes such representations to be true and
accurate based on information and data available to the company at this
time, actual results may differ materially from those described. The
company’s operations and business prospects are always subject to risk and
uncertainties. Important factors that may cause actual results to differ are
set forth in the company’s periodic filings with the U.S. Securities and
Exchange Commission.
|